The global negative pressure wound therapy market size is expected to reach USD 4.54 billion by 2033, registering a CAGR of 6.29% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing awareness in the developing regions pertaining to advanced wound care is providing a significant opportunity to the key market players to cater to the unmet needs of the target population. The primary driver associated with this market is the cost-effectiveness of single-use Negative Pressure Wound Therapy (NPWT) devices.
Major companies are also focusing on education of reimbursement coverage in such regions to further increase the affordability of these devices. However, the current reimbursement policies mostly cover conventional NPWT devices owing to their high cost. Furthermore, the geriatric population is also contributing to a great extent toward increasing the prevalence of chronic diseases. Increasing age is one of the high-risk factors leading to the development of chronic diseases such as atherosclerosis, which is one of the prime cardiovascular disorders prevalent in the geriatric population.
NPWT is one of the commonly accepted therapies employed for the treatment of arterial ulcers, which is one of the major complications of atherosclerosis. Around 50% of the people worldwide are exposed to fire-related traumas, among which, 90% of the cases occur in low to moderate-income countries. Thus, the rising incidence of traumatic events is expected to engender a high demand for negative pressure wound therapy products.
The COVID-19 pandemic significantly impacted the global NPTW market. Due to the restrictions imposed by regulatory authorities to minimize the spread of the virus, people have been restricted to their homes, resulting in a significant decrease in the incidences causing wounds to people. This has had a negative effect on the market as the demand for wound therapy significantly decreased. Although during the pandemic, diabetic wound therapy was continued due to its severity, other segments suffered a slight impact.
Request a free sample copy or view report summary: Negative Pressure Wound Therapy Market Report
By type, the NPWT accessories segment accounted for the largest market revenue share in 2025. The portable/disposable segment is anticipated to grow at the fastest CAGR during the forecast period.
By wound type, the chronic wounds segment accounted for the largest market revenue share in 2025. The acute wounds segment is expected to grow at the fastest CAGR during the forecast period.
By end-use, the hospitals segment accounted for the largest market revenue share of 45.38% in 2025. The home healthcare segment is expected to grow at the fastest CAGR during the forecast period.
North America dominated the global negative pressure wound therapy market with the largest revenue share of 43.81% in 2025. The negative pressure wound therapy industry in the U.S. accounted for the largest market revenue share in North America in 2025.
Grand View Research has segmented global negative pressure wound therapy market report based on the product, wound type, end-use, and region:
Negative Pressure Wound Therapy Product Outlook (Revenue, USD Million, 2021 - 2033)
Conventional NPWT Devices
Portable/Disposable NPWT
Disposable Portable NPWT
Reusable Portable NPWT
NPWT Accessories
Negative Pressure Wound Therapy Wound Type Outlook (Revenue, USD Million, 2021 - 2033)
Acute Wound
Surgical & Traumatic Wounds
Burns
Chronic Wound
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Other Chronic Wounds
Negative Pressure Wound Therapy End-use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Specialty Clinics
Home Healthcare
Others
Negative Pressure Wound Therapy Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Sweden
Denmark
Norway
Germany
UK
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of the Negative Pressure Wound Therapy Market
Smith & Nephew
Direct Healthcare Group
Convatec
DeRoyal Industries, Inc.
Medela (Medaxis LLC)
Paul Hartmann AG
Mölnlycke Health Care AB
3M (Solventum)
Cardinal Health
Genadyne Biotechnologies, Inc.
Pensar Medical (Lion Street Medical, LLC)
Alleva Medical Ltd.
Guard Medical
Triage Meditech Pvt. Ltd
L&R Group
Essity Aktiebolag (publ)
"The quality of research they have done for us has been excellent..."